当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析

瑞康医药

(002589)

  

流通市值:41.38亿  总市值:45.59亿
流通股本:13.66亿   总股本:15.05亿

瑞康医药(002589)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.16亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益544462.47万元,未分配利润24266.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1554653.15万元,负债1010190.67万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,707,482,764.517,295,858,461.635,406,533,649.773,543,520,195.09
营业总成本1,692,322,269.957,353,302,934.535,455,252,955.233,627,527,911.6
其他经营收益
营业利润16,451,078.916,851,413.4716,527,171.53-18,818,843.98
利润总额16,316,658.192,687,248.694,545,017.87-15,385,259.89
净利润15,619,562.143,902,130.2527,004,113.830,605,041.88
每股收益
其他综合收益----
综合收益总额15,619,562.143,902,130.2527,004,113.830,605,041.88
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计10,604,910,222.919,453,107,172.4210,443,029,336.1412,337,954,409.82
非流动资产:
非流动资产合计4,941,621,251.614,916,737,181.834,885,924,680.644,950,681,606.72
资产总计15,546,531,474.5214,369,844,354.2515,328,954,016.7817,288,636,016.54
流动负债:
流动负债合计9,656,108,240.618,661,925,568.69,398,039,209.2211,259,033,370.41
非流动负债:
非流动负债合计445,798,507.95285,177,120.38476,734,746.18463,677,272.39
负债合计10,101,906,748.568,947,102,688.989,874,773,955.411,722,710,642.8
所有者权益(或股东权益):
归属于母公司股东权益合计5,316,269,316.035,299,633,603.765,348,973,670.935,355,003,490.14
股东权益合计5,444,624,725.965,422,741,665.275,454,180,061.385,565,925,373.74
负债和股东权益合计15,546,531,474.5214,369,844,354.2515,328,954,016.7817,288,636,016.54
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,970,317,059.568,206,117,454.86,192,029,131.794,055,813,851.78
经营活动现金流出小计1,968,100,134.588,192,357,927.726,151,452,949.13,987,927,753.24
经营活动产生的现金流量净额2,216,924.9813,759,527.0840,576,182.6967,886,098.54
投资活动产生的现金流量:
投资活动现金流入小计367,281,071.371,698,391,040.58372,374,297.38231,494,480.42
投资活动现金流出小计461,145,2941,750,192,807.31499,479,265.73367,126,743.96
投资活动产生的现金流量净额-93,864,222.63-51,801,766.73-127,104,968.35-135,632,263.54
筹资活动产生的现金流量:
筹资活动现金流入小计4,323,188,181.5220,847,997,499.7213,337,365,337.149,128,738,056.04
筹资活动现金流出小计4,030,409,668.0720,782,039,199.1713,450,865,255.428,982,804,795.21
筹资活动产生的现金流量净额292,778,513.4565,958,300.55-113,499,918.28145,933,260.83
汇率变动对现金及现金等价物的影响-0--
现金及现金等价物净增加额201,131,215.827,916,060.9-200,028,703.9478,187,095.83
期末现金及现金等价物余额919,370,202.77718,238,986.97490,294,222.13768,510,021.9
补充资料:
现金及现金等价物的净增加额-27,916,060.9-78,187,095.83
TOP↑